Professional background
With a robust background in infectious diseases, Dr. Aboltins has contributed significantly to clinical research, particularly in the areas of prosthetic joint infections and the treatment of cellulitis. He has been involved in pivotal studies, including the Australasian COVID-19 Trial (ASCOT), which assessed clinical outcomes in hospitalized COVID-19 patients. Dr. Aboltins’ work is widely published in esteemed medical journals, reflecting his dedication to advancing medical knowledge and improving patient care.
Languages
- English
Telehealth
No
Client groups
- Adults
